Advanced Medical Solutions Group plc (AIM:AMS)
London · Delayed Price · Currency is GBP · Price in GBX 224.50
+0.50 (0.22%)
Oct 10, 2025, 7:00 PM GMT+1
AIM:AMS Market Cap
AIM:AMS has a market cap or net worth of 483.98 million as of October 10, 2025. Its market cap has increased by 4.10% in one year.
Market Cap
483.98M
Enterprise Value
547.71M
Revenue
220.30M
Ranking
n/a
PE Ratio
53.82
Stock Price
224.50
Market Cap Chart
Since April 11, 2000, AIM:AMS's market cap has increased from 11.11M to 483.98M, an increase of 4,257.40%. That is a compound annual growth rate of 15.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 483.98M | 14.26% |
| Dec 31, 2024 | 423.58M | -6.07% |
| Dec 29, 2023 | 450.96M | -19.69% |
| Dec 30, 2022 | 561.49M | -23.12% |
| Dec 31, 2021 | 730.32M | 39.54% |
| Dec 31, 2020 | 523.38M | -17.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 200.66B |
| GSK plc | 65.98B |
| Haleon | 30.29B |
| Smith & Nephew | 11.51B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 4.10B |
| HUTCHMED (China) | 1.99B |
| Genus | 1.75B |